Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Alcor Scientific LLC manages a patent portfolio in the Chemistry & Materials technology area. The portfolio currently has 1 pending office action. This workload is handled by 1 distinct examiner and 1 distinct art unit, which indicates a specific technical focus for the company's current filings. This distribution suggests that the company is currently prioritizing a technical development within the Chemistry & Materials field. The involvement of 1 distinct art unit indicates that the current prosecution is localized within a specific examination group.
NEIL N TURK is the busiest examiner for the portfolio with 1 busiest examiner pending action. This 1 action represents the total pending office actions for the company. With 1 distinct examiner involved, the prosecution process is currently concentrated on a specific matter. This centralized approach means that the outcome of the pending office action will define the current status of the company's active portfolio. Practitioners can focus their resources on this 1 pending action to effectively manage the company's intellectual property within the Chemistry & Materials sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TURK, NEIL N | 1 | 51.0% | +44.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17933986 | APPARATUS, METHOD, SYSTEM FOR THE DETERMINATION OF BLOODBORNE FACTORS INDICATIVE OF INFLAMMATION | TURK, NEIL N | 4d overdue |
| Art Unit | Apps |
|---|---|
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17933986 | APPARATUS, METHOD, SYSTEM FOR THE DETERMINATION OF BLOODBORNE FACTORS INDICATIVE OF INFLAMMATION | TURK, NEIL N | 1798 | §112Other | Final Rejection | 4d overdue | Pending | Sep 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial